. 2003 Mar 4;88(5):648–653. doi: 10.1038/sj.bjc.6600781

Table 1. Patient and tumour characteristics in 47 treated patients.

	Treatment group
	40 mg m⁻²n=16	35 mg m⁻²n=31
Age (years)
Median	67.5	60
Range	46–75	37–73
WHO performance status
0	10	22
1	6	9
2	0	0
Median	0	0
Sex
Female	6	11
Male	10	20
Prior surgery	15	29
Prior radiotherapy and/or adjuvant systemic therapy	3	7